Equities

Precision System Science Co Ltd

7707:TYO

Precision System Science Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)267.00
  • Today's Change3.00 / 1.14%
  • Shares traded150.40k
  • 1 Year change-5.32%
  • Beta1.0317
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments1,9152,4462,764
Total Receivables, Net8661,0822,184
Total Inventory1,6952,1441,832
Prepaid expenses------
Other current assets, total133199210
Total current assets4,6105,8726,990
Property, plant & equipment, net1,5813,3743,831
Goodwill, net------
Intangibles, net138345420
Long term investments558137
Note receivable - long term------
Other long term assets127891
Total assets6,3979,76211,410
LIABILITIES
Accounts payable382296405
Accrued expenses444663
Notes payable/short-term debt8008001,100
Current portion long-term debt/capital leases280552249
Other current liabilities, total453312401
Total current liabilities1,9592,0062,218
Total long term debt2922,5272,677
Total debt1,3723,8804,025
Deferred income tax1.973.16--
Minority interest------
Other liabilities, total1.132.503.84
Total liabilities2,2544,5404,898
SHAREHOLDERS EQUITY
Common stock1004,6444,644
Additional paid-in capital5,6981,1541,154
Retained earnings (accumulated deficit)(1714)(593)732
Treasury stock - common(23)(23)(23)
Unrealized gain (loss)------
Other equity, total82405.91
Total equity4,1435,2226,512
Total liabilities & shareholders' equity6,3979,76211,410
Total common shares outstanding282828
Treasury shares - common primary issue0.040.040.04
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.